Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched ...

Amgen's research chief said the company is very confident about its experimental obesity drug MariTide, as it prepares on ...

New research calls for routine risk stratification of MASLD in people with obesity to detect and manage liver disease earlier ...

Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...

A new definition of obesity could nearly double the prevalence of U.S. adults with the condition, a new study published ...

Arrowhead Pharmaceuticals has reported early-phase data on a pair of gene silencing drug candidates in obesity, posting ...

Nearly all of us have seen the ads and commercials for weight loss medications like Ozempic and Mounjaro, but how common are ...

The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is ...

Four recent deals fueled more angst about China’s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to ...

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and ...

CenterWell Pharmacy announced that it will dispense Eli Lilly's obesity drugs within employer weight management programs. | ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.